CIS001 Extension Study of Cyclosporine Inhalation Solution
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT00938236
- Locations
- ๐บ๐ธ
Cleveland Clinic, Cleveland, Ohio, United States
๐บ๐ธStanford University Medical Center, Stanford, California, United States
๐บ๐ธUCLA School of Medicine, Los Angeles, California, United States
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
- First Posted Date
- 2008-09-19
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Target Recruit Count
- 284
- Registration Number
- NCT00755781
- Locations
- ๐บ๐ธ
Mayo Clinic, Jacksonville, Florida, United States
๐บ๐ธStanford University Medical Center, Stanford, California, United States
๐บ๐ธUniversity of Florida Health Sciences Center, Gainesville, Florida, United States
Cyclosporine Inhalation Solution (CIS) in Lung Transplant Recipients
- Conditions
- Lung Transplant
- First Posted Date
- 2008-03-12
- Last Posted Date
- 2012-09-17
- Lead Sponsor
- APT Pharmaceuticals, Inc.
- Registration Number
- NCT00633373
- Locations
- ๐บ๐ธ
Cleveland Clinic, Cleveland, Ohio, United States
๐บ๐ธUniversity of California at San Francisco, San Francisco, California, United States
๐บ๐ธUniversity of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath